Literature DB >> 30768877

Postoperative complications increase the risk of long-term chronic kidney disease after nephron-sparing surgery in patients with renal cancer and normal preoperative renal function.

Eugenio Ventimiglia1,2, Alessandro Larcher1,2, Francesco Trevisani1, Fabio Muttin1,2, Francesco Cianflone1,2, Francesco Montorsi1,2, Andrea Salonia1,2, Roberto Bertini1,2, Umberto Capitanio1,2.   

Abstract

OBJECTIVES: To investigate whether postoperative complications affect long-term functional outcomes of renal patients treated with nephron-sparing surgery (NSS).
MATERIALS AND METHODS: We performed an observational study, enrolling 596 patients with preoperative normal renal function treated with NSS for clinical T1abN0M0 renal masses. Cox regression models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for chronic kidney disease (CKD) including as covariates age, comorbidity (scored according to the Charlson comorbidity index), hypertension, tumour size, preoperative estimated glomerular filtration rate (eGFR), eGFR < 60 mL/min/1.73 m2 at discharge, and ischaemia time.
RESULTS: A total of 137 patients (23%) developed postoperative complications. At a median (interquartile range) follow-up of 53 (26-91) months, CKD risk was 19% for patients with postoperative complications and 11% for those without complications. Patients experiencing postoperative complications (HR 1.90, 95% CI 1.26-2.86) were at increased risk of developing CKD during the follow-up at multivariable analysis, after accounting for confounders.
CONCLUSIONS: Our data outline how postoperative complications might have a detrimental impact on postoperative renal function in patients submitted to NSS. Improper patient selection, increasing the risk of postoperative complications, could limit the benefit in terms of renal function brought by NSS.
© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  #KidneyCancer; #kcsm; chronic kidney disease; complications; eGFR; nephron-sparing surgery

Mesh:

Year:  2019        PMID: 30768877     DOI: 10.1111/bju.14712

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  3 in total

1.  Cause-Specific Mortality Among Survivors From T1N0M0 Renal Cell Carcinoma: A Registry-Based Cohort Study.

Authors:  Zhixian Wang; Jing Wang; Yunpeng Zhu; Chang Liu; Xing Li; Xiaoyong Zeng
Journal:  Front Oncol       Date:  2021-03-10       Impact factor: 6.244

Review 2.  Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer.

Authors:  Francesco Trevisani; Matteo Floris; Roberto Minnei; Alessandra Cinque
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

Review 3.  The Role of Circulating Biomarkers in the Oncological Management of Metastatic Renal Cell Carcinoma: Where Do We Stand Now?

Authors:  Alessandra Cinque; Anna Capasso; Riccardo Vago; Michael W Lee; Matteo Floris; Francesco Trevisani
Journal:  Biomedicines       Date:  2021-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.